Oncology Update

Oncology Update

Michael Smart

ONF 2011, 39(1), 109-110. DOI: 10.1188/12.ONF.109-110

Cetuximab (Erbitux®) has been approved by the U.S. Food and Drug Administration (FDA) in combination with standard chemotherapy (a platinum plus 5-fluorouracil) for first-line treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN).

Jump to a section


    Chen, W. Y., Rosner, B., Hankinson, S. E., Colditz, G. A., & Willett, W. C. (2011). Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. JAMA, 306, 1884-1890. doi:10.1001/jama.2011.1590